Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
Bested, Alison C, Marshall, Lynn M · Reviews on environmental health · 2015 · DOI
Quick Summary
This review helps doctors understand ME/CFS better by explaining what it is, how to diagnose it, and how to treat it. ME/CFS is a serious illness that causes extreme tiredness, brain fog, pain, and sleep problems that get worse after physical activity. The review emphasizes that pacing activities—carefully balancing rest with gentle exercise—is one of the most important strategies patients can use to manage their symptoms and avoid crashes.
Why It Matters
This review is critical because most physicians lack training in ME/CFS diagnosis and management, leading to missed diagnoses and inappropriate care. By providing clinicians with practical diagnostic criteria and evidence-based management strategies, this work addresses a significant gap in medical education and can improve patient outcomes and reduce the substantial healthcare burden estimated at $17-24 billion annually in the US.
Observed Findings
Between 836,000 and 2.5 million Americans have ME/CFS according to Institute of Medicine estimates
80% of patients struggle to obtain an ME/CFS diagnosis because doctors lack training in diagnosis and management
29% of ME/CFS patients had unmet healthcare needs and 20% experienced food insecurity
ME/CFS is characterized by pathological fatigue and malaise worsened by exertion, cognitive dysfunction, immune dysfunction, unrefreshing sleep, and autonomic and neuroendocrine symptoms
Activity pacing with strategic rest periods is identified as the most important patient-managed coping strategy
Inferred Conclusions
ME/CFS is a complex, multifactorial disease with contributors from infectious, genetic, immune, metabolic, and neurological systems
Medical education gaps result in widespread underdiagnosis and inappropriate treatment, causing patient suffering
Patient-centered symptom management with activity pacing enables patients to regain functional capacity and avoid post-exertional malaise
Clinical recognition of ME/CFS as a legitimate organic illness is essential for improving healthcare outcomes and reducing societal costs
Remaining Questions
What is the precise biological etiology of ME/CFS and which mechanisms are primary drivers versus secondary effects?
What This Study Does Not Prove
This review does not prove the underlying biological causes of ME/CFS, nor does it present new experimental evidence supporting specific treatment mechanisms. It also does not provide randomized controlled trial data comparing different management approaches—it represents expert consensus and synthesis rather than testing specific therapeutic hypotheses.